Heterogeneity of Glycolytic Phenotype Determined by 18 F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer.

MLA

Pellegrino, Sara, et al. “Heterogeneity of Glycolytic Phenotype Determined by 18 F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer.” Diagnostics (Basel, Switzerland), vol. 13, no. 14, July 2023. EBSCOhost, https://doi.org/10.3390/diagnostics13142448.

APA

Pellegrino, S., Fonti, R., Hakkak Moghadam Torbati, A., Bologna, R., Morra, R., Damiano, V., Matano, E., De Placido, S., & Del Vecchio, S. (2023). Heterogeneity of Glycolytic Phenotype Determined by 18 F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer. Diagnostics (Basel, Switzerland), 13(14). https://doi.org/10.3390/diagnostics13142448

Chicago

Pellegrino, Sara, Rosa Fonti, Armin Hakkak Moghadam Torbati, Roberto Bologna, Rocco Morra, Vincenzo Damiano, Elide Matano, Sabino De Placido, and Silvana Del Vecchio. 2023. “Heterogeneity of Glycolytic Phenotype Determined by 18 F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer.” Diagnostics (Basel, Switzerland) 13 (14). doi:10.3390/diagnostics13142448.